RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 127 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $794,000 | -87.6% | 702,773 | -67.1% | 0.14% | -82.7% |
Q1 2022 | $6,390,000 | +449.0% | 2,137,128 | +386.4% | 0.84% | +385.5% |
Q4 2021 | $1,164,000 | -3.7% | 439,356 | +27.2% | 0.17% | +226.4% |
Q4 2020 | $1,209,000 | -27.5% | 345,529 | -50.3% | 0.05% | -56.2% |
Q3 2020 | $1,668,000 | -45.8% | 695,529 | -58.6% | 0.12% | -50.6% |
Q2 2020 | $3,075,000 | +17.3% | 1,680,529 | 0.0% | 0.24% | +24.4% |
Q1 2020 | $2,622,000 | +250.1% | 1,680,529 | +380.2% | 0.20% | +62.8% |
Q4 2019 | $749,000 | – | 350,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |